Michael acceptor containing drugs are a novel class of 5‐lipoxygenase inhibitor targeting the surface cysteines C416 and C418
暂无分享，去创建一个
D. Steinhilber | M. Karas | M. Parnham | B. Hofmann | G. Geisslinger | C. Matrone | T. Maier | G. Manolikakes | Michael Rühl | J. Roos | Isabelle V. Maucher | Benjamin Kühn | Jasmin Fettel | Nadine Hellmuth | M. Piesche | Anja Vogel | S. Kretschmer | Vahid Golghalyani | Karsten Flügel | A. Ball | Ann‐Kathrin Häfner | Matthias Piesche